The most common side effect of topiramate is paresthesia, a tingling or “pins and needles” sensation typically felt in the hands, feet, and face. In clinical trials for migraine prevention, 51% of adults taking 100 mg per day reported tingling, making it far more frequent than any other side effect. The sensation is usually harmless but can be persistent.
How Common Tingling Is Across Doses
Tingling appears to be dose-dependent. In pooled migraine trials involving adolescents, 20% of those on 50 mg per day reported it, 19% on 100 mg per day, and 38% on 200 mg per day, compared to just 7% on placebo. In epilepsy trials with adults taking 200 to 400 mg per day, paresthesia was still common but other side effects like drowsiness and dizziness were more prominent at those higher doses.
The tingling tends to start during the first few weeks as the dose is being increased. Some studies suggest it resolves on its own over time, but at least one study found it persisted for as long as patients continued the medication. If tingling hasn’t appeared within the first six weeks of reaching a stable dose, it’s unlikely to start later.
Other Frequently Reported Side Effects
Beyond tingling, the side effect profile shifts depending on whether topiramate is being used for migraines or epilepsy.
For migraine prevention (100 mg per day in adults), the most common reactions after tingling were:
- Fatigue: 15%
- Loss of appetite: 15%
- Nausea: 13%
- Diarrhea: 11%
For epilepsy (200 to 400 mg per day in adults), the picture looked different:
- Drowsiness: 29%
- Dizziness: 25%
- Nervousness: 16%
- Poor coordination: 16%
- Fatigue: 15%
The higher doses used for epilepsy tend to produce more sedation and balance problems, while the lower migraine doses are more associated with tingling and appetite changes.
Cognitive Effects and Word-Finding Trouble
Topiramate has earned the nickname “dopamax” among patients for a reason. In a one-year follow-up study of people taking low-dose topiramate for epilepsy, 44% reported cognitive problems. The most frequent complaints were difficulty concentrating, memory gaps, slower thinking, and trouble finding the right word mid-sentence. Even at low doses, researchers found measurable long-term effects on working memory and verbal fluency.
These cognitive effects can sometimes be managed by increasing the dose very slowly in small steps, giving the brain time to adjust. Most cognitive side effects show up during the initial dose-increase period. If you haven’t noticed thinking changes within the first one to two months, they’re unlikely to develop later. However, for people who do experience them early on, the problems tend to stick around for as long as the medication is continued.
Weight Loss and Appetite Suppression
Topiramate consistently causes weight loss, which is unusual among seizure and migraine medications (many cause weight gain). In an analysis of randomized controlled studies lasting at least 16 weeks, people taking topiramate alongside lifestyle changes lost an average of about 5.3 kilograms, or roughly 12 pounds. In longer studies specifically looking at weight in people with obesity, participants lost 5% to 7% of their starting body weight over six months.
This effect is driven partly by appetite suppression and partly by changes in how food tastes. Topiramate blocks an enzyme called carbonic anhydrase, which plays a role in how your tongue perceives carbonation and certain flavors. Some people find that carbonated drinks taste flat or metallic, and food in general becomes less appealing. Clinical trial reports often listed “taste disturbance” as a side effect, though the exact percentage varied because studies defined it differently.
Kidney Stones and Metabolic Changes
Topiramate increases the risk of kidney stones by roughly 58% compared to people not taking the drug, based on a large study tracking symptomatic stone events. The risk was highest in people under 39, where it nearly doubled. This happens because the same enzyme-blocking effect that changes taste also shifts the chemistry of your urine, making it more alkaline and reducing citrate levels, both of which encourage calcium phosphate stones to form.
The medication can also lower bicarbonate levels in the blood, creating a mild acid imbalance. This drop usually happens early in treatment but can occur at any point. Most cases are mild, though levels have occasionally fallen well below the normal range. Symptoms of this imbalance can include fatigue, loss of appetite, and faster breathing, though many people have no noticeable symptoms at all. Staying well hydrated is a practical step that helps reduce kidney stone risk.
When Side Effects Typically Appear
Most side effects cluster during the titration period, the first several weeks when your dose is being gradually increased. A study tracking the time course of topiramate’s most common adverse events in migraine patients found that side effects leading to people stopping the medication almost always occurred during this window. If you reach six weeks on your target dose without experiencing a particular side effect, it’s unlikely to appear later.
This pattern is why doctors typically start topiramate at a low dose and increase it slowly over several weeks. Rushing the dose increase tends to make cognitive effects and tingling more intense. For people who do develop side effects early, the key question is whether they improve with time. Tingling may or may not fade. Cognitive symptoms tend to persist if they’ve appeared, though some people adapt. Appetite suppression and weight loss generally continue for as long as you take the medication.